epidural fentanyl
PreclinicalSmall molecule
epidural fentanyl is one of 3 small molecule programs targeting Immune Function. It is currently in Preclinical.
1
Indications
3
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
2 competitors in Immune Function
#DrugCompanyPhaseTrials
1CAR T Cells
CChongqing Precision Biotech Co., Ltd
Phase 1
Tdap
PfizerPreclinical
epidural fentanyl
ZZagazig University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Dexamethasone1 trial
Immune Function1 trial
The Effect of Epidural Fentanyl on Immune Function
Unknown status·MMcGill University Health Centre/Research Institute of the McGill University Health Centre·N/A·NCT01646775·30 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for epidural fentanyl. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- ZZagazig University